Avenue Therapeutics Inc.

Avenue Therapeutics, Inc. develops specialty therapies for neurologic diseases, featuring AJ201 (Phase 1b/2a for spinal and bulbar muscular atrophy), IV tramadol for post‑operative pain, and BAER‑101 for epilepsy and panic disorders. Subsidiary of Fortress Biotech.

Headquarters: United States (USA)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Manufacturing
Industry: Pharmaceutical Manufacturing

Employees: 2
HQ: Bay Harbor Islands

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
ATXI	Avenue Therapeutics Inc. Cap: 0.0B \| P/E: 0.8	EQUITY	NMS	USD	US05360L2051	Active	📈